Roche Warns Of Counterfeit Avastin

Feb. 16 | Swiss global health-care company Roche on February 15 warned that counterfeit versions of its cancer-fighting drug Avastin had been discovered in circulation in the US. The FDA issued a statement saying: “The counterfeit version of Avastin does...

FDA Approved Gleevec In Rare Gastrointestinal Cancer For Expanded Use In Patients

Feb. 8 | The U.S. Food and Drug Administration (FDA) granted Gleevec (imatinib) regular approval for use in adult patients following surgical removal of CD117-positive gastrointestinal stromal tumors (GIST). This highlights an increase in overall patient survival...

Good Clinical Practices For Ayurvedic Drugs In India

Feb. 8 | The Department of Ayush has recently issued a circular making clinical trials mandatory for all the existing and new ayurvedic medicinal products in the country. A set of guidelines has been already prepared by the Department for the purpose and it plans...

FDA Approved Erivedge For Most Common Type Of Skin Cancer

Feb. 8 | The U.S. Food and Drug Administration (FDA) approved Erivedge (vismodegib) to treat adult patients with basal cell carcinoma, the most common type of skin cancer. The drug is intended for use in patients with locally advanced basal cell cancer who are...

Supreme Court Sent Notice To Centre On Illegal Drug Trials

Feb. 8 | The Supreme Court of India sent notice to the Central Government on 6 February, 2011 on a writ petition alleging that illegal clinical trials of untested drugs were being conducted by pharmaceutical companies on adults, children and even mentally ill...

National Policy On Narcotic Drugs Unveiled

Feb. 8 | The Union government of India unveiled a comprehensive policy on narcotic drugs and psychotropic substances. The need for such a policy assumes significance in the light of the fact that trafficking in narcotic drugs also contributes to generation of...

Side Effects Of Breast Cancer Drug

Feb. 8 | Exemestane, a commonly used drug, administered on patients in early breast cancer in India- as frequently as once a day for five years – has been found to cause significant bone loss, even when patients are given adequate calcium and vitamin D intake....

FDA Approved Janumet XR For Type 2 Diabetes

Feb. 8 | The U.S. Food and Drug Administration (FDA) approved JANUMET XR (sitagliptin and metformin hydrochloride (HCl) extended-release) tablets, a new treatment for type 2 diabetes that combines sitagliptin, which is the active component of JANUVIA® (sitagliptin),...

Yet Another Clue In The Mystery Of Autism

Feb. 6 | The genetic basis of autism is now well established and a growing body of research also suggests that environmental factors may play a role in this serious developmental disorder affecting nearly one in 100 children. A new study by using a unique study...

FDA Approved Cystic Fibrosis Drug By Vertex Pharmaceuticals

Feb. 6 | The U.S. Food and Drug Administration (FDA) has approved KALYDECO (ivacaftor), the first medicine to treat the underlying cause of cystic fibrosis (CF), a rare, genetic disease. KALYDECO (kuh-LYE-deh-koh) is approved for people with CF ages 6 and older...